Valuation: ZIM Laboratories Limited

Market Cap 6.43B 66.57M 58.5M 54.35M 50M 93.81M 95.56M 649M 253M 3.15B 250M 245M 10.91B P/E 2025
32.1x
P/E 2026 50.3x
Enterprise Value 7.29B 75.51M 66.35M 61.65M 56.71M 106M 108M 736M 287M 3.57B 283M 277M 12.38B EV / Sales 2025
1.34x
EV / Sales 2026 1.09x
Free-Float
28.79%
Yield 2025 *
-
Yield 2026 -
1 day-2.00%
1 week-0.50%
Current month-3.42%
1 month-4.27%
3 months+38.26%
6 months+68.89%
Current year+66.99%
1 week 120.05
Extreme 120.05
125.5
1 month 111.5
Extreme 111.5
133.95
Current year 59.72
Extreme 59.72
133.95
1 year 59.72
Extreme 59.72
133.95
3 years 59.72
Extreme 59.72
151.75
5 years 36.37
Extreme 36.3667
151.75
10 years 14
Extreme 14
151.75
Manager TitleAgeSince
Chief Executive Officer - 2001-12-31
Director of Finance/CFO - 2019-03-31
Director of Finance/CFO - 1990-12-31
Director TitleAgeSince
Chairman - 1989-12-31
Director/Board Member - 1990-12-31
Director/Board Member - 2012-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%-0.50%+2.91%+0.04% 67.98M
+0.57%+0.13%+16.45%+78.10% 48.31B
-0.50%-0.41%+67.13%+107.90% 35.33B
-1.56%-3.13%-4.88%+32.80% 11.85B
-1.11%-3.73%+16.41%+81.64% 11.64B
-0.37%-0.19%+36.48%+136.73% 8.99B
-0.27%+0.42%+51.66%-6.22% 6.93B
-0.77%-3.00%+13.55%+32.01% 6.72B
+0.24%-4.02%+2.19%+192.78% 6.43B
+1.60%-9.55%-30.77%+8.47% 5.66B
Average -0.42%-1.21%+17.11%+66.43% 14.19B
Weighted average by Cap. -0.15%-0.93%+27.59%+81.82%

Financials

2025 2026
Net sales 3.79B 39.26M 34.5M 32.06M 29.49M 55.32M 56.36M 383M 149M 1.85B 147M 144M 6.43B 3.74B 38.77M 34.07M 31.66M 29.12M 54.63M 55.65M 378M 147M 1.83B 146M 142M 6.35B
Net income 122M 1.26M 1.11M 1.03M 946K 1.78M 1.81M 12.28M 4.79M 59.52M 4.73M 4.63M 206M 58.38M 605K 531K 494K 454K 852K 868K 5.89M 2.3M 28.56M 2.27M 2.22M 99.09M
Net Debt 1.16B 11.99M 10.53M 9.79M 9M 16.89M 17.21M 117M 45.6M 566M 45M 44.03M 1.96B 863M 8.94M 7.85M 7.3M 6.71M 12.59M 12.83M 87.12M 33.99M 422M 33.55M 32.83M 1.46B
Logo ZIM Laboratories Limited
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Employees
632
Date Price Change Volume
26-07-23 ₹120.05 -2.00% 500
26-07-21 ₹122.50 -2.00% 400
26-07-20 ₹125.00 -0.36% 2,296
26-07-17 ₹125.45 +1.95% 8,530
26-07-16 ₹123.05 +1.99% 3,069
  1. Stock Market
  2. Stocks
  3. ZIMLAB Stock